Reduced ENG or ACVRL1 activity, owing to loss-of-function mutations, leads to the human disease hereditary haemorrhagic telangiectasia (HHT) (Johnson et al., 1996; McAllister et al., 1994; Snodgrass et al., 2021). This evidence concerns the gene ACVRL1 and hereditary hemorrhagic telangiectasia.